ANTICATARACT POTENTIAL OF BARLERIA PRIONITIS: IN VIVO STUDY
Objective: The present study was formulated in order to evaluate the Anticataract potential of Barleria prionitis using Selenite and Galactose induced cataract models.
Methods: Barleria prionitis (Family-Acanthaceae), used in mythical system possessing antioxidant activity was evaluated for its Anticataract potential. The ability of Barleria prionitis to tweak the biochemical parameters was explored in these studies. Selenite cataract was incited in 10 days old pups by subcutaneous infusion of sodium Selenite (25 moles/kg of body weight). The rats in the test gathering were infused with Barleria prionitis (200 and 400 mg/kg body weight, p. o.) 4 h before the Selenite administration. The rate of cataract was watched when the rats initially opened their eyes on 16th day. Galactose cataract was actuated in rats by sustaining 30% Galactose in the eating regimen. Rats in the test gathering were sustained orally with 200 and 400 mg/kg of Barleria prionitis every day and rats in the control gathering got just vehicle. Cataract stages were evaluated at normal interims.
Results: In this study, morphological assessment demonstrated that Selenite treated gathering demonstrates increased opacities when contrasted with normal gathering. A fall in the glutathione level and a climb in the Malondialdehyde levels were seen in control rather than normal lenses. Administration of Barleria prionitis significantly restored the glutathione and Malondialdehyde levels. SOD, Catalase and Glutathione S transferase levels were significantly restored to normal levels (p<0.05 and p<0.01 respectively). Oral administration of Barleria prionitis significantly delayed the onset and progression of cataract in Selenite as well as Galactose induced cataract.
Conclusion: The Anticataract potential is evident from the slit lamp microscopic images. It can be said that Barleria prionitis significantly reversed the cataract parameters by virtue of its antioxidant potential, which may be useful for further molecular studies to determine the exact mechanism for its Anticataract potential.
2. Rivlin RS. Historical perspective on the use of garlic. J Nutr 2001;131(3s):951-4.
3. Patel DK, Prasad SK, Kumar R, Hemlatha S. â€œCataract: a major secondary complication of diabetes, its epidemiology and an overview on major medicinal plants screened for Anticataract activityâ€. Asian Pac J Trop Dis 2011;323-9.
4. Harding J. The epidemiology of Cataract. In: Harding J, ed. Cataract-biochemistry, epidemiology and pharmacology. 1st ed. Madras Chapman & Hall; 1991. p. 83.
5. Spector A. Oxidative stress induced cataract: mechanism of action. FASEB J 1995;9:1173.
6. Gupta SK, Joshi S, Srivastava S, Trivedi D, Halder N. â€œHerbal ophthalmic formulation for preventing cataractâ€ world intellectual property organization, International publication nuber WO 03/080091 A1; 2003. p. 1-22.
7. Devamanoharan PS, Henein M, Ali AH, Varma SD. Attenuation of sugar cataract by ethyl pyruvate. Molecular Cell Biochem 1999;200:103.
8. Gerster H. Antioxidant vitamins in cataract prevention. Z Ernahrungswiss 1989;28:56-75.
9. Gupta SK, Joshi S, Srivastava S, Trivedi D, Halder N, Varma SD. â€œ Green tea (Camellia sinensis) protects against selenite induced oxidative stress in experimental cataractogenesisâ€. Ophthalmic Res 2002;34:258-63.
10. Khare CP. Indian Herbal Remedies, Rational Western Therapy, Ayurvedic and other Traditional Usage, Botany, 1st Edition; 2004. p. 93-4.
11. Kulkarni SK. Handbook of experimental pharmacology, second ed. Vallabh Prakashan, Mumbai; 1993.
12. Harborne JB. Phytochemical methods: A guide to modern techniques of plant analysis. 2nd Guidance edition, New York: Chapman and Hall; 1984.
13. Kokate CK. A textbook of Pharmacognosy 45th ed. Vallabh Prakashan, New Delhi; 2010.
14. Khandelwal KR. Practical pharmacognosy techniques and experiments, Second edition. Nirali Prakashan, Pune; 2000. p. 149-56.
15. Trease, GE, Evans WC. A Textbook of Pharmacognosy. 13th edition, Bailliere Tindall Ltd: London; 1989.
16. Gupta SK, Deepa T, Srivastava S, Joshi S, Halder N, Verma SD. Lycopene attenuates oxidative stress induced experimental cataract development: an in vitro and in vivo study. Nutr 2003;19;794-9.
17. Shenoy AM. Evaluation of cataract prevention action of phycocyanin. Int J Pharm Sci Drug Res 2011;3(1):42-4.
18. Sheare TR, David LL, Anderson RS. Review of selenite cataract. Curr Eye Res 1992;11:357-69.